NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for antiretroviral


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV
2009 NOV 23 ... HIV protease inhibitors with ritonavir to increase the blood levels of these antiretroviral drugs prescribed to treat HIV infection. However, significant complications are ...
Subject: Concert Pharmaceuticals, Inc.
Price: $3.00
*
Data from INSERM advance knowledge in HIV/AIDS
2009 NOV 23 ... (HIV) infection is well documented, especially with regard to adherence to highly active antiretroviral therapy (HAART). We used the data from a 5-year longitudinal study of the MANIF 2000 ...
Subject: HIV/AIDS
Price: $3.00
*
Data from University of Pittsburgh advance knowledge in virology
2009 NOV 23 ... by stimulation with HIV-1 peptide-loaded DC derived from HIV-1-infected subjects on antiretroviral therapy. We first found that mature DC increased the number of gamma interferon ...
Subject: Virology
Price: $3.00
*
Data on HIV/AIDS co-infection published by C.P. Bhunu and colleagues
2009 NOV 23 ... a study from Bulawayo, Zimbabwe, "An HIV/AIDS and TB coinfection model which considers antiretroviral therapy for the AIDS cases and treatment of all forms of TB, i.e., latent and active ...
Subject: HIV/AIDS Co-Infection
Price: $3.00
*
Data on immune reconstitution inflammatory syndrome published by researchers at University of KwaZulu-Natal
2009 NOV 23 ... CD1 and CD2) with expert opinion in a prospective cohort of patients who were starting antiretroviral therapy in South Africa." "A total of 498 adult patients were monitored ...
Subject: Immune Reconstitution Inflammatory Syndrome
Price: $3.00
*
Findings from S. Vanderborght and co-authors provide new insights into HIV/AIDS
2009 NOV 23 ... company with operations in several African countries was committed to offer antiretroviral treatment to its employees and their dependants. Approach The Accelerating Access ...
Subject: HIV/AIDS
Price: $3.00
*
New HIV/AIDS findings from University of California described
2009 NOV 23 ... between HIV stigma and: self-reported access to care, regular source of HIV care, and antiretroviral therapy adherence; and to test whether mental health mediates these associations. ...
Subject: HIV/AIDS
Price: $3.00
*
New research on HIV/AIDS co-infection from University of Florida summarized
2009 NOV 23 ... to treat, given the propensity for drug interactions between the rifamycins and the antiretroviral drugs. We examined the pharmacokinetics of rifabutin before and after the addition of ...
Subject: HIV/AIDS Co-Infection
Price: $3.00
*
President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical Department
2009 NOV 17 ... access to health care on a national scale. Today, one in three people with HIV taking antiretroviral therapy receive services at a facility that has benefited from Abbott Fund support. ...
Subject: Abbott
Price: $3.00
*
Recent studies from Johns Hopkins University, Department of Neurology add new data to virology
2009 NOV 23 ... along neuronal pathways. Importantly, its production is not impacted by the use of antiretroviral drugs once the proviral DNA has been formed," wrote W. Li and colleagues, Johns Hopkins ...
Subject: Virology
View Free
Daily News
Article
Relief Group Says Simple, Effective Tactic in Global AIDS Fight Also One of Most Neglected
2009 NOV 23 ... pregnant women, which is essential in order to be able to test mothers for HIV and begin antiretroviral therapy that can cut the risk of mother-to-child transmission to virtually zero. Even ...
Subject: World Vision
Price: $3.00
*
Reports from M. Genebat and co-researchers add new data to research in HIV/AIDS
2009 NOV 23 ... began an 8 day exposure to maraviroc (MCT group); six HIV-infected patients without antiretroviral therapy received no treatment (control group). Plasma viral load was evaluated on days ...
Subject: HIV/AIDS
Price: $3.00
*
Reports from Tufts University describe recent advances in virology
2009 NOV 23 ... "Patients infected with Human immunodeficiency virus (HIV) living longer with antiretroviral therapy (ART) are more likely to develop non-AIDS-defining cancers such as ...
Subject: Virology
Price: $3.00
*
Reports outline HIV/AIDS study findings from Y. Yazdanpanah and colleagues
2009 NOV 23 ... active drugs in human immunodeficiency virus (HIV)-infected patients receiving failing antiretroviral therapy is a key determinant of subsequent treatment efficacy. The aim of this study was ...
Subject: HIV/AIDS
Price: $3.00
*
Research from Northwestern University, Division of Infectious Diseases reveals new findings on HIV/AIDS risk factors
2009 NOV 23 ... to achieve high CD4 cell counts while receiving virally suppressive highly active antiretroviral therapy (HAART) are uncertain. We analysed data from HIV-infected men participating in ...
Subject: HIV/AIDS Risk Factors
View Free
Daily News
Article
Studies from A. Bourgarit et al have provided new data on HIV/AIDS co-infection
2009 NOV 23 ... syndrome (IRS) is a frequent event (10 to 30%) in HIV-1-infected patients receiving antiretroviral treatment and is associated with an increased number of IFN-gamma-producing ...
Subject: HIV/AIDS Co-Infection
Price: $3.00
*
Studies from A. Talwar et al add new findings in the area of virology
2009 NOV 23 ... human immunodeficiency virus (HIV)-infected patients after the introduction of combined antiretroviral therapy, pulmonary arterial hypertension (PAH) has become an important cause of ...
Subject: Virology
Price: $3.00
*
Study data from C. Voils and co-authors update knowledge of life sciences
2009 NOV 16 ... for the synthesis of evidence from qualitative and quantitative reports: the example of antiretroviral medication adherence. Journal of Health Services Research & Policy, 2009;14(4):226-233). ...
Subject: Life Sciences
Price: $3.00
*
Study data from University of London update knowledge of HIV/AIDS
2009 NOV 23 ... and stakeholders felt there was an ethical obligation to ensure effective access to antiretroviral drugs and to provide supportive community-based care for women identified as HIV ...
Subject: HIV/AIDS
Price: $3.00
*
Study results from G. Morsica and colleagues in the area of hepatitis B virus published
2009 NOV 16 ... these patients. Of the 1,593 HIV-positive subjects enrolled in the Italian Cohort Naive Antiretroviral (ICONA) program, 175 (10.9%) were selected for inclusion in the study on the basis of ...
Subject: Hepatitis B Virus
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login